Dulaglutide, semaglutide, and tirzepatide exhibit comparable gastrointestinal adverse event risk
1. In this cohort study, dulaglutide, semaglutide, and tirzepatide demonstrated similar risks of gastrointestinal adverse events (AEs) in…
Wales allows surgery patients access to weight loss jabs
The Welsh government has announced that the weight-loss drug tirzepatide (Mounjaro) will be made available to patients needing…
Eli Lilly, Tan France launch Zepbound ‘Changing the Thread’
New innovative campaign weaves science and storytelling to help reframe obesity as a chronic disease INDIANAPOLIS, Nov. 10,…
Mounjaro mounts to top spot in Indian drug market; Oct sales touch ₹100 cr, ETPharma
New Delhi: Maintaining its growth momentum for the seventh straight month, Eli Lilly’s type-2 diabetes and weight-loss drug…
Walmart making it easier to get super-popular weight loss drug Zepbound for 50% off
A new partnership between Walmart and drug maker Eli Lily will make it easier for people to access…
Ozempic vs Mounjaro vs Wegovy: Prices in India vs US and what the research actually shows
Ozempic, Mounjaro, Wegovy: Guide to Weight Loss Injections and Their Cost in India vs US Ozempic, Mounjaro and…
From Wegovy to Ozempic: Which drugs are really APPROVED for weight loss in India, how costly are they?
Lost 120 kgs in 16 months, 55 kgs in 18 months, 20kgs in XX months and so on…in…